ID
12654
Beschrijving
Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT00130195
Link
https://clinicaltrials.gov/show/NCT00130195
Trefwoorden
Versies (1)
- 08-12-15 08-12-15 -
Geüploaded op
8 december 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Lymphoblastic Leukemia NCT00130195
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
Beschrijving
another severe and/or life-threatening disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
positive for hiv antibody and/or hepatitis b surface (hbs) antigen tests
Datatype
boolean
Alias
- UMLS CUI [1]
- C0149709
- UMLS CUI [2]
- C0019699
Beschrijving
another primary malignancy which is clinically active
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschrijving
pregnant or breastfeeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Beschrijving
renal failure
Datatype
boolean
Alias
- UMLS CUI [1]
- C1533077
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00130195
- StudyEvent: Eligibility
C1835417 (UMLS CUI [2])
C0232805 (UMLS CUI [2])
C0428772 (UMLS CUI [3])
C0019699 (UMLS CUI [2])
C0006147 (UMLS CUI [2])